• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD).2 型糖尿病患者 8 年死亡率的预测因素:糖尿病转化研究行动(TRIAD)。
Diabetes Care. 2012 Jun;35(6):1301-9. doi: 10.2337/dc11-2281. Epub 2012 Mar 19.
2
Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study.糖尿病患者死亡的危险因素:糖尿病转化研究行动(TRIAD)研究
Diabetes Care. 2007 Jul;30(7):1736-41. doi: 10.2337/dc07-0305. Epub 2007 Apr 27.
3
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.HbA1c 水平与超重和肥胖 2 型糖尿病心血管高危男女患者心血管不良结局和全因死亡率的关系。
Diabetologia. 2012 Sep;55(9):2348-55. doi: 10.1007/s00125-012-2584-3. Epub 2012 May 26.
4
Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus.估计青少年和青年成年人诊断为 2 型糖尿病的发病率和死亡率。
Diabet Med. 2012 Apr;29(4):453-63. doi: 10.1111/j.1464-5491.2011.03542.x.
5
Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.糖化血红蛋白A1c与成人心血管疾病及死亡率的关联:诺福克欧洲癌症前瞻性调查研究
Ann Intern Med. 2004 Sep 21;141(6):413-20. doi: 10.7326/0003-4819-141-6-200409210-00006.
6
Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.高血糖和脂蛋白成分异常作为2型糖尿病患者心血管死亡的预测因素:自诊断起15年随访研究
Diabetes Care. 1998 Nov;21(11):1861-9. doi: 10.2337/diacare.21.11.1861.
7
HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes.HbA1c 诊断后 3 个月可预测新发 2 型糖尿病患者的过早死亡。
Diabet Med. 2011 Dec;28(12):1520-4. doi: 10.1111/j.1464-5491.2011.03443.x.
8
Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.2型糖尿病患者代谢控制、心血管风险及干预措施中的性别差异。
Gend Med. 2010 Dec;7(6):571-83. doi: 10.1016/j.genm.2010.12.001.
9
Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.糖化血红蛋白对 2 型糖尿病患者发病率和全因死亡率的短期影响:一项丹麦基于人群的观察性研究。
Diabetologia. 2012 Sep;55(9):2361-70. doi: 10.1007/s00125-012-2614-1. Epub 2012 Jun 27.
10
Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes.尿中α1-抗胰蛋白酶可预测2型糖尿病患者的心血管及全因死亡率。
Diabetologia. 2002 Jan;45(1):115-20. doi: 10.1007/s125-002-8251-3.

引用本文的文献

1
Machine learning driven diabetes care using predictive-prescriptive analytics for personalized medication prescription.使用预测性-规范性分析进行个性化药物处方的机器学习驱动的糖尿病护理。
Sci Rep. 2025 Jul 23;15(1):26811. doi: 10.1038/s41598-025-12310-1.
2
Cardiovascular and renal comorbidities among saudi patients with type 2 diabetes: A cross-sectional observational study.沙特2型糖尿病患者的心血管和肾脏合并症:一项横断面观察性研究。
PLoS One. 2025 May 27;20(5):e0324233. doi: 10.1371/journal.pone.0324233. eCollection 2025.
3
Comparison of mortality in people with type 2 diabetes between different ethnic groups: Systematic review and meta-analysis of longitudinal studies.不同种族2型糖尿病患者死亡率的比较:纵向研究的系统评价和荟萃分析
PLoS One. 2025 Jan 17;20(1):e0314318. doi: 10.1371/journal.pone.0314318. eCollection 2025.
4
Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?加纳一家三级医院中2型糖尿病患者的死亡率预测模型及决定因素,机器学习技术表现如何?
BMC Endocr Disord. 2025 Jan 10;25(1):9. doi: 10.1186/s12902-025-01831-5.
5
Development and validation of a nomogram of all-cause mortality in adult Americans with diabetes.开发并验证了一个针对美国成年糖尿病患者全因死亡率的列线图。
Sci Rep. 2024 Aug 19;14(1):19148. doi: 10.1038/s41598-024-69581-3.
6
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.二甲双胍和阿托伐他汀联合治疗与单药治疗 2 型糖尿病伴血脂异常患者的疗效和安全性(ATOMIC):双盲随机对照试验。
Diabetes Metab J. 2024 Jul;48(4):730-739. doi: 10.4093/dmj.2023.0077. Epub 2024 May 20.
7
The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9.循环系统、胰腺局部的前蛋白转化酶枯草溶菌素9(PCSK9)与2型糖尿病之间的关联:抗糖尿病药物对PCSK9的影响。
Heliyon. 2023 Aug 29;9(9):e19371. doi: 10.1016/j.heliyon.2023.e19371. eCollection 2023 Sep.
8
Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.晚期糖基化终末产物:糖尿病心血管并发症的关键介质和治疗靶点。
World J Diabetes. 2023 Aug 15;14(8):1146-1162. doi: 10.4239/wjd.v14.i8.1146.
9
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes.瘦型/正常体重 2 型糖尿病的病理生理学的现有知识。
Int J Mol Sci. 2022 Dec 30;24(1):658. doi: 10.3390/ijms24010658.
10
Developing a prediction model for all-cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China.建立中国上海 2 型糖尿病患者全因死亡率风险预测模型。
J Diabetes. 2023 Jan;15(1):27-35. doi: 10.1111/1753-0407.13343. Epub 2022 Dec 16.

本文引用的文献

1
Predicting 6-year mortality risk in patients with type 2 diabetes.预测2型糖尿病患者的6年死亡风险。
Diabetes Care. 2008 Dec;31(12):2301-6. doi: 10.2337/dc08-1047. Epub 2008 Sep 22.
2
Development and validation of an all-cause mortality risk score in type 2 diabetes.2型糖尿病全因死亡风险评分的开发与验证
Arch Intern Med. 2008 Mar 10;168(5):451-7. doi: 10.1001/archinte.168.5.451.
3
Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study.糖尿病患者死亡的危险因素:糖尿病转化研究行动(TRIAD)研究
Diabetes Care. 2007 Jul;30(7):1736-41. doi: 10.2337/dc07-0305. Epub 2007 Apr 27.
4
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study.将糖尿病作为死因上报:糖尿病转化研究行动(TRIAD)研究结果
Diabetes Care. 2006 Feb;29(2):247-53. doi: 10.2337/diacare.29.02.06.dc05-0998.
5
How to measure comorbidity. a critical review of available methods.如何测量共病。对现有方法的批判性综述。
J Clin Epidemiol. 2003 Mar;56(3):221-9. doi: 10.1016/s0895-4356(02)00585-1.
6
A primer and comparative review of major US mortality databases.美国主要死亡率数据库入门与比较综述
Ann Epidemiol. 2002 Oct;12(7):462-8. doi: 10.1016/s1047-2797(01)00285-x.
7
The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care.糖尿病研究转化为行动(TRIAD)研究:一项管理式医疗中糖尿病的多中心研究。
Diabetes Care. 2002 Feb;25(2):386-9. doi: 10.2337/diacare.25.2.386.
8
Recording of diabetes on death certificates. Has it improved?死亡证明上糖尿病的记录。情况有改善吗?
J Clin Epidemiol. 2001 Mar;54(3):239-44. doi: 10.1016/s0895-4356(00)00303-6.
9
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.多变量预后模型:模型开发、评估假设与充分性以及测量和减少误差方面的问题。
Stat Med. 1996 Feb 28;15(4):361-87. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
10
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.纵向研究中预后合并症分类的一种新方法:开发与验证
J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.

2 型糖尿病患者 8 年死亡率的预测因素:糖尿病转化研究行动(TRIAD)。

Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD).

机构信息

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Diabetes Care. 2012 Jun;35(6):1301-9. doi: 10.2337/dc11-2281. Epub 2012 Mar 19.

DOI:10.2337/dc11-2281
PMID:22432119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3357242/
Abstract

OBJECTIVE

To examine demographic, socioeconomic, and biological risk factors for all-cause, cardiovascular, and noncardiovascular mortality in patients with type 2 diabetes over 8 years and to construct mortality prediction equations.

RESEARCH DESIGN AND METHODS

Beginning in 2000, survey and medical record information was obtained from 8,334 participants in Translating Research Into Action for Diabetes (TRIAD), a multicenter prospective observational study of diabetes care in managed care. The National Death Index was searched annually to obtain data on deaths over an 8-year follow-up period (2000-2007). Predictors examined included age, sex, race, education, income, smoking, age at diagnosis of diabetes, duration and treatment of diabetes, BMI, complications, comorbidities, and medication use.

RESULTS

There were 1,616 (19%) deaths over the 8-year period. In the most parsimonious equation, the predictors of all-cause mortality included older age, male sex, white race, lower income, smoking, insulin treatment, nephropathy, history of dyslipidemia, higher LDL cholesterol, angina/myocardial infarction/other coronary disease/coronary angioplasty/bypass, congestive heart failure, aspirin, β-blocker, and diuretic use, and higher Charlson Index.

CONCLUSIONS

Risk of death can be predicted in people with type 2 diabetes using simple demographic, socioeconomic, and biological risk factors with fair reliability. Such prediction equations are essential for computer simulation models of diabetes progression and may, with further validation, be useful for patient management.

摘要

目的

在 8 年时间内,研究 2 型糖尿病患者的全因、心血管和非心血管死亡率的人口统计学、社会经济和生物学风险因素,并构建死亡率预测方程。

研究设计和方法

从 2000 年开始,通过对 Translating Research Into Action for Diabetes(TRIAD)的 8334 名参与者进行调查和病历信息收集,开展了一项多中心前瞻性观察性研究,以评估糖尿病管理中的护理情况。通过每年搜索国家死亡索引,获得了 8 年随访期间(2000-2007 年)的死亡数据。研究中检查了年龄、性别、种族、教育程度、收入、吸烟状况、糖尿病诊断年龄、糖尿病持续时间和治疗、BMI、并发症、合并症以及药物使用等预测因素。

结果

在 8 年期间,有 1616 例(19%)死亡。在最简洁的方程中,全因死亡率的预测因素包括年龄较大、男性、白种人、收入较低、吸烟、胰岛素治疗、肾病、血脂异常史、较高的 LDL 胆固醇、心绞痛/心肌梗死/其他冠状动脉疾病/冠状动脉成形术/旁路移植术、充血性心力衰竭、阿司匹林、β受体阻滞剂和利尿剂的使用以及较高的 Charlson 指数。

结论

使用简单的人口统计学、社会经济和生物学风险因素可以预测 2 型糖尿病患者的死亡风险,其可靠性尚可。这些预测方程对于糖尿病进展的计算机模拟模型至关重要,并且可能在进一步验证后,对患者管理有用。